These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 17879398)
1. Survivin expression in early hepatocellular carcinoma and post-treatment with anti-cancer drug under hypoxic culture condition. Mamori S; Asakura T; Ohkawa K; Tajiri H World J Gastroenterol; 2007 Oct; 13(40):5306-11. PubMed ID: 17879398 [TBL] [Abstract][Full Text] [Related]
2. Nuclear translocation of survivin in hepatocellular carcinoma: a key to cancer cell growth? Moon WS; Tarnawski AS Hum Pathol; 2003 Nov; 34(11):1119-26. PubMed ID: 14652813 [TBL] [Abstract][Full Text] [Related]
3. Relationship between survivin expression and recurrence, and prognosis in hepatocellular carcinoma. Ye CP; Qiu CZ; Huang ZX; Su QC; Zhuang W; Wu RL; Li XF World J Gastroenterol; 2007 Dec; 13(46):6264-8. PubMed ID: 18069771 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of Stat3 activity by YC-1 enhances chemo-sensitivity in hepatocellular carcinoma. Lau CK; Yang ZF; Lam SP; Lam CT; Ngai P; Tam KH; Poon RT; Fan ST Cancer Biol Ther; 2007 Dec; 6(12):1900-7. PubMed ID: 18059167 [TBL] [Abstract][Full Text] [Related]
5. Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma. Ikeguchi M; Ueta T; Yamane Y; Hirooka Y; Kaibara N Clin Cancer Res; 2002 Oct; 8(10):3131-6. PubMed ID: 12374680 [TBL] [Abstract][Full Text] [Related]
6. Clinicopathological significance of survivin expression in patients with hepatocellular carcinoma. Chau GY; Lee AF; Tsay SH; Ke YR; Kao HL; Wong FH; Tsou AP; Chau YP Histopathology; 2007 Aug; 51(2):204-18. PubMed ID: 17559540 [TBL] [Abstract][Full Text] [Related]
7. Relationship between expression of Smac and Survivin and apoptosis of primary hepatocellular carcinoma. Bao ST; Gui SQ; Lin MS Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):580-3. PubMed ID: 17085346 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus X protein upregulates survivin expression in hepatoma tissues. Zhang X; Dong N; Yin L; Cai N; Ma H; You J; Zhang H; Wang H; He R; Ye L J Med Virol; 2005 Nov; 77(3):374-81. PubMed ID: 16173017 [TBL] [Abstract][Full Text] [Related]
9. Expression and significance of new inhibitor of apoptosis protein survivin in hepatocellular carcinoma. Zhu H; Chen XP; Zhang WG; Luo SF; Zhang BX World J Gastroenterol; 2005 Jul; 11(25):3855-9. PubMed ID: 15991282 [TBL] [Abstract][Full Text] [Related]
10. Survivin overexpression in HCC and liver cirrhosis differentially correlates with p-STAT3 and E-cadherin. Peroukides S; Bravou V; Alexopoulos A; Varakis J; Kalofonos H; Papadaki H Histol Histopathol; 2010 Mar; 25(3):299-307. PubMed ID: 20054802 [TBL] [Abstract][Full Text] [Related]
11. Clinical value of apoptosis and angiogenesis factors in estimating the prognosis of hepatocellular carcinoma. Guo RP; Zhong C; Shi M; Zhang CQ; Wei W; Zhang YQ; Li JQ J Cancer Res Clin Oncol; 2006 Sep; 132(9):547-55. PubMed ID: 16763805 [TBL] [Abstract][Full Text] [Related]
12. [Effect of inhibiting survivin expression with antisense oligodeoxynucleotides on sensitivity of hepatocellular carcinoma cell lines HepG2 and HepG2/ADM to adriamycin]. Dai DJ; Lu CD; Guo JM; Zhang J Ai Zheng; 2005 Aug; 24(8):951-7. PubMed ID: 16086872 [TBL] [Abstract][Full Text] [Related]
13. Survivin in survival of hepatocellular carcinoma. Su C Cancer Lett; 2016 Sep; 379(2):184-90. PubMed ID: 26118774 [TBL] [Abstract][Full Text] [Related]
14. [Expression of survivin, p27 and PTEN in hepatocellular carcinoma and their clinical significances]. Huang AM; Ding Y; Liu JF; Gao LY; Zang SB; Chen SP Zhonghua Gan Zang Bing Za Zhi; 2008 Jan; 16(1):17-20. PubMed ID: 18226337 [TBL] [Abstract][Full Text] [Related]
15. Anticancer drugs are synergistic with freezing in induction of apoptosis in HCC cells. Yuan F; Zhou W; Zhang J; Zhang Z; Zou C; Huang L; Zhang Y; Dai Z Cryobiology; 2008 Aug; 57(1):60-5. PubMed ID: 18586021 [TBL] [Abstract][Full Text] [Related]
16. Galectin-1 Modulates the Survival and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Sensitivity in Human Hepatocellular Carcinoma Cells. Li J; Sun RR; Yu ZJ; Liang H; Shen S; Kan Q Cancer Biother Radiopharm; 2015 Oct; 30(8):336-41. PubMed ID: 26348206 [TBL] [Abstract][Full Text] [Related]
17. Expression of survivin mRNA associates with apoptosis, proliferation and histologically aggressive features in hepatocellular carcinoma. Morinaga S; Nakamura Y; Ishiwa N; Yoshikawa T; Noguchi Y; Yamamoto Y; Rino Y; Imada T; Takanashi Y; Akaike M; Sugimasa Y; Takemiya S Oncol Rep; 2004 Dec; 12(6):1189-94. PubMed ID: 15547736 [TBL] [Abstract][Full Text] [Related]
18. [Expressions of Survivin and vascular endothelial growth factor in hepatocellular carcinoma and their clinical significance]. Cui F; Chen B; Chen JZ; Huang YX; Luo RC Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):761-3. PubMed ID: 18504198 [TBL] [Abstract][Full Text] [Related]
19. Epigenetic methylation and expression of caspase 8 and survivin in hepatocellular carcinoma. Cho S; Lee JH; Cho SB; Yoon KW; Park SY; Lee WS; Park CH; Joo YE; Kim HS; Choi SK; Rew JS Pathol Int; 2010 Mar; 60(3):203-11. PubMed ID: 20403046 [TBL] [Abstract][Full Text] [Related]
20. [Interleukin-12 enhanced tumor necrosis factor related apoptosis-inducing ligand TRAIL-induced apoptosis in human hepatocellular carcinoma by inhibiting expression of survivin]. He SQ; Chen Y; Chen XP; Zhang WG; Wang HP; Zhang BX Zhonghua Wai Ke Za Zhi; 2003 Jun; 41(6):453-7. PubMed ID: 12895357 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]